Parenteral Drugs India gets nod for final restructuring package

12 Nov 2012 Evaluate

Parenteral Drugs India has received an approval from Corporate Debt Restructuring (CRD) Cell, Mumbai on November 08, 2012 for final restructuring package. Necessary steps pursuant to the approval are being taken by the lenders.

PDPL is the pioneer company making 400 mg Ciprofloxacin infusion in 200 ml with 5% dextose. The I.V. fluids are packed in size ranging from 100 ml to 3 litre and dialysis solution up to 10 litres water for injection is manufactured with the help of hi-tech From-Fill-seal machine ranging from 1 ml to 10 ml.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1811.65
Dr. Reddys Lab 1349.00
Cipla 1472.70
Lupin 2155.35
Zydus Lifesciences 971.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.